This project was co-funded by the European Regional Development Fund (ERDF) with the aim of promoting technological development, innovation and high-quality research.
PROBELTE PHARMA, S.L.U.
“DEVELOPMENT OF A NEW VACCINE FOR VARIOUS HYMENOPTERA VENOM ALLERGIES WITH IMPROVED EFFICACY AND GREATER CHEMICAL AND FUNCTIONAL STABILITY”
A way of making Europe
